Related references
Note: Only part of the references are listed.Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects
M. Boyce et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature
Matilde Pia Spampatti et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Type I Gastric Carcinoids: A Prospective Study on Endoscopic Management and Recurrence Rate
Elettra Merola et al.
NEUROENDOCRINOLOGY (2012)
Development of type I gastric carcinoid in patients with chronic atrophic gastritis
L. Vannella et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Mechanism of Acid Hypersecretion Post Curative Gastrinoma Resection
Jeremiah V. Ojeaburu et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids
Constantin S. Jianu et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Laparoscopic Antrectomy for the Treatment of Type I Gastric Carcinoid Tumors
Junko Ozao-Choy et al.
JOURNAL OF SURGICAL RESEARCH (2010)
The CCK2 receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development
M. Kidd et al.
REGULATORY PEPTIDES (2010)
Neuroendocrine Tumor Epidemiology Contrasting Norway and North America
Oyvind Hauso et al.
CANCER (2008)
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours
Simona Grozinsky-Glasberg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition
Reidar Fossmark et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Well-differentiated gastric tumors/carcinomas
Philippe Ruszniewski et al.
NEUROENDOCRINOLOGY (2006)
One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release
V Fykse et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Gastric carcinoids -: Biologic behavior and prognosis after differentiated treatment in relation to type
K Borch et al.
ANNALS OF SURGERY (2005)
Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer
S Takaishi et al.
GASTROENTEROLOGY (2005)
Gastric carcinoid tumours. Is there a place for antrectomy?
P Guillem
ANNALES DE CHIRURGIE (2005)
Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids
M Peracchi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Rebound acid hypersecretion after long-term inhibition of gastric acid secretion
R Fossmark et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas
ML Richards et al.
WORLD JOURNAL OF SURGERY (2004)
Treatment of ECL cell carcinoids with octreotide LAR
V Fykse et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
A 50-year analysis of 562 gastric carcinoids: Small tumor or larger problem?
IM Modlin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome - A prospective study of 107 cases and comparison with 1009 cases from the literature
F Gibril et al.
MEDICINE (2004)
ECL-cell derived gastric cancer in male cotton rats dosed with the H2-blocker loxtidine
R Fossmark et al.
CANCER RESEARCH (2004)
Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist
TC Martinsen et al.
CARCINOGENESIS (2003)
Gastrin agonists and antagonists
JW Black et al.
PHARMACOLOGY & TOXICOLOGY (2002)
Validation of a liquid chromatographic-tandem mass spectrometric method for the measurement of (R)-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea (YF476) in human plasma
MJ Redrup et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia
G Qvigstad et al.
APMIS (2002)
Letter to the editor
HL Waldum et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2001)
Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer
TC Wang et al.
GASTROENTEROLOGY (2000)